← Leaderboards
Maureen Agnes Sartor
University Of Michigan At Ann Arbor
$7,415,011
Attributed
$16,633,489
Total exposure
12
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.4M · FY2011–25$5M$3.8M$2.5M$1.3M$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$16,633,489 · 12
By mechanism
R01$12,232,860 · 4
T32$1,976,806 · 2
P30$1,759,081 · 3
R21$369,768 · 1
P01$294,974 · 2
Top collaborators
- Laura Rozek13 shared
- Stuart A Batterman5 shared
- Nisha J D'Silva5 shared
- Eva L Feldman5 shared
- Stephen Goutman5 shared
- Ivo D Dinov3 shared
- Arvind Rao2 shared
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Charles F Burant$27,360,950
- Eva L Feldman$26,770,746
- Brian David Athey$25,019,937
- Suzanne E Judd$21,734,940
- Thomas E. Carey$14,226,111
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularTranscriptomicsEpigenetic ProcessEpigenomicsSamplingLinkMichiganGenomeBaseInnovationGenomicsGenome-WideBioinformaticsBiological MarkersMalignant NeoplasmsGene ExpressionPathway InteractionsLifeComplexHuman PapillomavirusTumorGeneticDna MethylationSite
Grant awards (36)
Integrating the exposome and epigenome identifies determinants of ALS risk, survival, and pathogenesis$3,133,754
R01 · FY2025 · ES
Pan Omics and Data Science Core$230,035
P30 · FY2025 · ES · contact PI
Developing novel strategies for personalized treatment and prevention of ALS: Leveraging the global exposome, genome, epigenome, metabolome, and inflammasome with data science in a case/control cohort$719,029
R01 · FY2024 · NS
Downstream effects of HPV integration on survival/metastasis in oropharyngeal cancer$517,177
R01 · FY2024 · CA · contact PI
Proteogenomics of Cancer Training Program$370,831
T32 · FY2024 · CA · contact PI
Pan Omics and Data Science Core$228,829
P30 · FY2024 · ES · contact PI
Developing novel strategies for personalized treatment and prevention of ALS: Leveraging the global exposome, genome, epigenome, metabolome, and inflammasome with data science in a case/control cohort$736,527
R01 · FY2023 · NS
Downstream effects of HPV integration on survival/metastasis in oropharyngeal cancer$575,080
R01 · FY2023 · CA · contact PI
Biomedical Informatics and Data Science Training Program (BIDS-TP)$424,428
T32 · FY2023 · GM
Proteogenomics of Cancer Training Program$375,155
T32 · FY2023 · CA · contact PI
Pan Omics and Data Science Core$229,107
P30 · FY2023 · ES · contact PI
Core 2: Immune Bioinformatics and Computational Biology Core$134,367
P01 · FY2023 · CA · contact PI
Developing novel strategies for personalized treatment and prevention of ALS: Leveraging the global exposome, genome, epigenome, metabolome, and inflammasome with data science in a case/control cohort$984,329
R01 · FY2022 · NS
Downstream effects of HPV integration on survival/metastasis in oropharyngeal cancer$584,593
R01 · FY2022 · CA · contact PI
Biomedical Informatics and Data Science Training Program (BIDS-TP)$416,289
T32 · FY2022 · GM
Pan Omics and Data Science Core$229,371
P30 · FY2022 · ES · contact PI
Core 2: Immune Bioinformatics and Computational Biology Core$160,607
P01 · FY2022 · CA · contact PI
Developing novel strategies for personalized treatment and prevention of ALS: Leveraging the global exposome, genome, epigenome, metabolome, and inflammasome with data science in a case/control cohort$989,984
R01 · FY2021 · NS
Downstream effects of HPV integration on survival/metastasis in oropharyngeal cancer$584,072
R01 · FY2021 · CA · contact PI
Biomedical Informatics and Data Science Training Program (BIDS-TP)$390,103
T32 · FY2021 · GM
Downstream effects of HPV integration on survival/metastasis in oropharyngeal cancer$216,973
R01 · FY2021 · CA · contact PI
Downstream effects of HPV integration on survival/metastasis in oropharyngeal cancer$575,516
R01 · FY2020 · CA · contact PI
Omics and Bioinformatics Facility Core$177,582
P30 · FY2020 · ES · contact PI
Omics and Bioinformatics Facility Core$172,605
P30 · FY2019 · ES · contact PI
Omics and Bioinformatics Facility Core$167,749
P30 · FY2018 · ES · contact PI
Omics and Bioinformatics Facility Core$142,499
P30 · FY2017 · ES · contact PI
Omics and Bioinformatics Facility Core$181,304
P30 · FY2016 · ES · contact PI
5-hydroxymethylcytosine in HPV(+) and HPV(-) oral and oropharyngeal cancers$134,302
R21 · FY2016 · CA · contact PI
Integrative epigenomic/genomic profiling and biomarker discovery in HPV+ and HPV-$421,253
R01 · FY2015 · CA
5-hydroxymethylcytosine in HPV(+) and HPV(-) oral and oropharyngeal cancers$235,466
R21 · FY2015 · CA · contact PI
Integrative epigenomic/genomic profiling and biomarker discovery in HPV+ and HPV-$185,506
R01 · FY2015 · CA
Integrative epigenomic/genomic profiling and biomarker discovery in HPV+ and HPV-$410,990
R01 · FY2014 · CA
Integrative epigenomic/genomic profiling and biomarker discovery in HPV+ and HPV-$192,127
R01 · FY2014 · CA
Integrative epigenomic/genomic profiling and biomarker discovery in HPV+ and HPV-$436,873
R01 · FY2013 · CA
Integrative epigenomic/genomic profiling and biomarker discovery in HPV+ and HPV-$476,822
R01 · FY2012 · CA
Integrative epigenomic/genomic profiling and biomarker discovery in HPV+ and HPV-$492,255
R01 · FY2011 · CA